Patients with heart failure (HF) who have worsening HF symptoms that require intensification of oral diuretics in the outpatient setting are common and associated with a poor prognosis, and finerenone ...
Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF ...
JACC: Case Reports is seeking your patient success stories! Share your cases, vignettes and team discussions on patients with failing heart conditions who were ultimately treated successfully. Whether ...
American Board of Cardiovascular Medicine Chair Jeffrey Kuvin, MD, issued the following statement in response to the American Board of Medical Specialties denial of an independent board for cardiology ...
A new clinical guideline released by the ACC and the American Heart Association includes new evidence and updated recommendations for managing patients with acute ...
Tafamidis treatment in octogenarians diagnosed with wild-type transthyretin cardiomyopathy (ATTRwt-CM) improves survival without age affecting treatment efficacy, although mortality remains ...
A State-of-the-Art Review published on Feb. 26 in JACC: Basic to Translational Science highlights the potential of emerging thrombolytic therapies such as antagonists of fibrinolysis inhibitors to ...
The definition of a high-risk plaque should be expanded beyond the traditional focus on plaque rupture and thin-cap fibroatheroma in the setting of acute coronary syndromes (ACS), according to a new ...
Cardiopulmonary fitness and physical activity levels were significantly lower in children with inherited cardiac disease than in healthy controls, according to a study published Feb. 25 in JAMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback